Sanchay Finvest Limited has announced a board meeting scheduled for January 30, 2026, at 4:00 P.M. to deliberate on significant corporate matters including authorized capital enhancement and modifications to its preferential issue framework.

Board Meeting Agenda

The board meeting, to be held at the company's registered office, will address several key items as outlined in the company's regulatory filing dated January 27, 2026.

Key Matters for Consideration

The board will primarily focus on two critical corporate actions during the scheduled meeting:

• Authorized Capital Increase: The directors will evaluate and potentially approve an enhancement to the company's authorized capital structure
• Preferential Issue Amendment: Modifications to the preferential issue that was originally approved on January 5, 2026

Background on Preferential Issue

The company had previously conducted a board meeting on January 5, 2026, where directors approved a proposal for issuing equity shares on a preferential basis to selected allottees. This preferential issue represents a strategic capital-raising initiative for the company.

Allottee Participation Confirmation

A significant development has emerged regarding the preferential issue, with Mr. Sagar Tilokchand Kothari, one of the proposed preferential allottees, formally communicating his intention to participate in the offering. This confirmation provides clarity on investor interest and participation levels for the planned equity issuance.

Regulatory Compliance

The board meeting announcement has been made in accordance with Regulation 29(1) and 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company continues to maintain transparency with stakeholders through timely regulatory disclosures and proper governance protocols.

Sanchay Finvest Ltd announced significant corporate developments following its board meeting held on January 5, 2026, including a substantial preferential share allotment and authorised capital enhancement. The company's board approved multiple strategic initiatives that require shareholder approval through an upcoming Extraordinary General Meeting.

Preferential Share Allotment Details

The board approved the issuance of up to 48.50 lakh equity shares through preferential allotment, raising ₹48.50 crores at ₹10.00 per share. The allotment will be made to five non-promoter investors, with the largest allocation going to Anil Babubhai Mehta.

All proposed allottees currently hold no existing shares in the company, making this their initial investment. The issue price of ₹10.00 per share matches the face value of the equity shares.

Authorised Capital Enhancement

To accommodate the preferential allotment, the board proposed increasing the company's authorised capital from ₹8.00 crores to ₹12.00 crores. This enhancement requires amendment to the Memorandum of Association under Section 13 of the Companies Act, 2013, subject to shareholder approval in the upcoming EGM.

Corporate Governance and Compliance

The company has obtained a valuation report from CA Jay Ashok Shah, an IBBI Registered Valuer, and a Regulation 163(2) certificate from Mr. Ramesh Chandra Mishra, Practicing Company Secretary. The relevant date for the preferential issue has been fixed as January 9, 2026. Mr. Ramesh Chandra Mishra has also been appointed as scrutinizer for the e-voting process during the EGM.

Extraordinary General Meeting and Office Relocation

The board scheduled an Extraordinary General Meeting for February 9, 2026, at 3:00 PM to seek shareholder approval for all proposed resolutions. Additionally, the board approved the relocation of the company's registered office from Madhya Pradesh to Maharashtra. The company will provide e-voting facilities through the CSDL platform for shareholder convenience.

Meeting Duration and Leadership

The board meeting, which commenced at 4:00 PM and concluded at 9:00 PM on January 5, 2026, was conducted under the leadership of Managing Director Naresh Kumar Nandlal Sharma. All decisions were made in compliance with SEBI regulations and the Companies Act, 2013, ensuring proper disclosure and transparency for stakeholders.